Instrument Inactif

Communiqués Arena Pharmaceuticals, Inc. Nasdaq

Actions

US0400471027

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Biopharma Stocks Targeting Crohn's Disease In $13.7 Billion Market (STAB, ARNA, GILD and RDHL)	16/03/22	AQ
Pfizer Completes Acquisition of Arena Pharmaceuticals	14/03/22	AQ
Arena Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K	11/03/22	PU
ARENA PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	11/03/22	AQ
ARENA PHARMACEUTICALS INC : Other Events (form 8-K)	10/03/22	AQ
ARENA PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23/02/22	AQ
Arena Pharmaceuticals : Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates - Form 8-K	23/02/22	PU
Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates	23/02/22	BU
ARENA PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)	18/02/22	AQ
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	17/02/22	BU
Pfizer's announced purchase of Arena Pharmaceuticals exemplifies a satisfactory acquisition within the CBD medical treatment industry	15/02/22	AQ
Arena Pharmaceuticals to Release Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update on February 23	09/02/22	BU
ARENA PHARMACEUTICALS INC : Other Events (form 8-K)	07/02/22	AQ
ARENA PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)	02/02/22	AQ
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	19/01/22	AQ
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	18/01/22	BU
ARENA PHARMACEUTICALS INC : Other Events (form 8-K)	07/01/22	AQ
ARENA PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)	22/12/21	AQ
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	21/12/21	BU
Harley-Davidson, Arena rise; Capital One, Carnival fall	13/12/21	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Arena Pharmaceuticals, Inc. Nasdaq

Actions

US0400471027

Communiqués

Filtres